Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05263492
Title Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Virginia Commonwealth University
Indications

endometrial cancer

Therapies

Lenvatinib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST